Items where authors include "Kunst, Natalia"

Article

Kunst, Natalia orcid.org/0000-0002-2409-4246, Long, Jessica B, Westvold, Sarah et al. (10 more authors) (2024) Long-Term Outcomes of Prostate-Specific Membrane Antigen-PET Imaging of Recurrent Prostate Cancer. JAMA network open. e2440591. ISSN 2574-3805

Dijk, Stijntje W, Krijkamp, Eline, Kunst, Natalia orcid.org/0000-0002-2409-4246 et al. (7 more authors) (2024) Making Drug Approval Decisions in the Face of Uncertainty:Cumulative Evidence versus Value of Information. Medical Decision Making. ISSN 1552-681X

Knauss, Tara, Hansen, Bo T, Pedersen, Kine et al. (3 more authors) (2023) The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway:The Equalscreen randomized controlled trial. Gynecologic oncology. pp. 39-47. ISSN 1095-6859

Jaber Chehayeb, Rachel, Hood, Annette, Wang, Xiaoliang et al. (7 more authors) (2022) Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021. JAMA network open. e2244204. ISSN 2574-3805

Heath, Anna, Strong, Mark, Glynn, David orcid.org/0000-0002-0989-1984 et al. (3 more authors) (2022) Simulating Study Data to Support Expected Value of Sample Information Calculations:A Tutorial. Medical Decision Making. pp. 143-155. ISSN 1552-681X

Yang, Szu-Chun, Kunst, Natalia orcid.org/0000-0002-2409-4246, Gross, Cary P et al. (3 more authors) (2021) Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer. Frontiers in Oncology. 760686. ISSN 2234-943X

Kim, David D, Silver, Madison C, Kunst, Natalia orcid.org/0000-0002-2409-4246 et al. (3 more authors) (2020) Correction to : Perspective and Costing in Cost‑Effectiveness Analysis, 1974-2018. Pharmacoeconomics. p. 1377. ISSN 1179-2027

Kunst, Natalia orcid.org/0000-0002-2409-4246, Wang, Shi-Yi, Hood, Annette et al. (4 more authors) (2020) Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)-Positive Breast Cancer. JAMA network open. e2027074. ISSN 2574-3805

Kim, David D, Silver, Madison C, Kunst, Natalia orcid.org/0000-0002-2409-4246 et al. (3 more authors) (2020) Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018. Pharmacoeconomics. pp. 1135-1145. ISSN 1179-2027

Kunst, Natalia orcid.org/0000-0002-2409-4246, Wilson, Edward C F, Glynn, David orcid.org/0000-0002-0989-1984 et al. (11 more authors) (2020) Computing the Expected Value of Sample Information Efficiently:Practical Guidance and Recommendations for Four Model-Based Methods. Value in Health. pp. 734-742. ISSN 1524-4733